Product Wiki · Recalls · Health Canada — Medical Devices

RAPIDPoint® 500e Blood Gas System — recall 74411

Health Canada — Medical Devices · Canada · 2023-10-12 · Type II

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Agency
Health Canada — Medical Devices
Recall identifier
74411
Date of alert
2023-10-12
Country / jurisdiction
Canada
Risk level
Type II
Risk type
recall
Product category
Chemistry
Product type
Medical devices
Reported risk: Siemens Healthcare Diagnostics Inc. has determined that two drugs, perhexiline maleate and atomoxetine hydrochloride, may interfere with sodium results that are reported on the RAPIDPoint® 500 and RAPIDPoint® 500e Blood Gas Systems. Recall start date: October 2, 2023
Primary source: https://recalls-rappels.canada.ca/en/alert-recall/rapidpointr-500e-blood-gas-sys

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

Related

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.